Literature DB >> 9867794

Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.

Y W Chu, E T Houang, A F Cheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867794      PMCID: PMC105997     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  16 in total

1.  Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii.

Authors:  Y Nishino; T Deguchi; M Yasuda; T Kawamura; M Nakano; E Kanematsu; S Ozeki; Y Kawada
Journal:  FEMS Microbiol Lett       Date:  1997-09-15       Impact factor: 2.742

2.  A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

3.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.

Authors:  J H Kim; E H Cho; K S Kim; H Y Kim; Y M Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.

Authors:  M Georgiou; R Muñoz; F Román; R Cantón; R Gómez-Lus; J Campos; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

7.  Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.

Authors:  Y W Chu; E T Houang; D J Lyon; J M Ling; T K Ng; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

8.  Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.

Authors:  Y Kumagai; J I Kato; K Hoshino; T Akasaka; K Sato; H Ikeda
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.

Authors:  P Heisig; R Tschorny
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.

Authors:  J Vila; J Ruiz; P Goñi; M T De Anta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more
  4 in total

1.  Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones.

Authors:  Kenji Hirose; Jun Terajima; Hidemasa Izumiya; Kazumichi Tamura; Eiji Arakawa; Nobuko Takai; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.

Authors:  L E Lindler; W Fan; N Jahan
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.

Authors:  J M Ling; E W Chan; A W Lam; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Phenotypic and molecular characterization of antimicrobial resistant Escherichia coli from urinary tract infections in Port-Harcourt, Nigeria.

Authors:  Adebola Onanuga; Jaspreet Mahindroo; Shreya Singh; Neelam Taneja
Journal:  Pan Afr Med J       Date:  2019-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.